These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26709138)

  • 1. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
    Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
    J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1α,25-Dihydroxyvitamin D
    Ben-Eltriki M; Deb S; Guns EST
    J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tumor Effects of Ginsenoside 20(S)-Protopanaxadiol and 1,25-Dihydroxyvitamin D3 Combination in Castration Resistant Prostate Cancer.
    Ben-Eltriki M; Deb S; Shankar G; Meckling G; Hassona M; Yamazaki T; Fazli L; Chin MY; Tomlinson Guns ES
    Medicines (Basel); 2021 Jun; 8(6):. PubMed ID: 34199743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
    Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES
    Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
    Musende AG; Eberding A; Jia W; Ramsay E; Bally MB; Guns ET
    Prostate; 2010 Sep; 70(13):1437-47. PubMed ID: 20687217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction of calcitriol with 20(S)-protopanaxadiol in mice: Determined by LC/MS analysis.
    Ben-Eltriki M; Hassona M; Meckling G; Adomat H; Deb S; Tomlinson Guns ES
    Eur J Pharm Sci; 2019 Mar; 130():173-180. PubMed ID: 30654110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective.
    Ben-Eltriki M; Shankar G; Tomlinson Guns ES; Deb S
    Cancer Chemother Pharmacol; 2023 Dec; 92(6):419-437. PubMed ID: 37709921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
    Deb S; Chin MY; Adomat H; Guns ES
    J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.
    Ben-Eltriki M; Deb S; Hassona M; Meckling G; Fazli L; Chin MY; Lallous N; Yamazaki T; Jia W; Rennie PS; Cherkasov A; Tomlinson Guns ES
    Oncotarget; 2018 Apr; 9(30):20965-20978. PubMed ID: 29765513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
    Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
    Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
    Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
    Wang JY; Swami S; Krishnan AV; Feldman D
    Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
    Zhao Y; Bu L; Yan H; Jia W
    Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
    Reagan-Shaw S; Nihal M; Ahsan H; Mukhtar H; Ahmad N
    Prostate; 2008 Nov; 68(15):1624-34. PubMed ID: 18668529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
    Wang W; Wang H; Rayburn ER; Zhao Y; Hill DL; Zhang R
    Br J Cancer; 2008 Feb; 98(4):792-802. PubMed ID: 18253123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.